|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.0308 - 0.0361|
|52 Week Range||0.0215 - 0.1737|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announces that it has completed its previously announced at-the-market equity financing program (the "ATM Program"). Under the ATM Program, the Company sold an aggregate of 433,426,063 common shares of the Company ("Common Shares") between May 4, 2021, and September 17, 2021. The Common Shares were sold at prevailing market prices for aggregate gross proceeds of approximately C$20,000,000.
Halo Collective Inc. ("Halo") (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) today announced that its wholly-owned subsidiary, Bophelo Bioscience & Wellness (Pty) Ltd. ("Bophelo"), has signed a processing and distribution agreement with Cantourage GmbH, ("Cantourage") one of Europe's leading providers of medical cannabis. With this agreement, Bophelo has secured a path to market to the rapidly growing European medical cannabis market for products cultivated at its current 5-hectare campus with futur
Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) today announced the official launch of Ztrawberriez and 4 Prophets premium cannabis flower, the first two strains stemming from the Company's strategic partnership with DNA Genetics to exclusively develop DNA Genetics brands in the state of Oregon through breeding, growing, phenotyping and processing. The award-winning genetics can be found on the shelves of leading dispensaries throughout Oregon.